Efficacy of azilsartan medoxomil in patients with hypertension and stable coronary artery disease in combination with type 2 diabetes
Aim. To study the effect of azilsartan medoxomil (AZL-M) on the 24-hour blood pressure (BP) profile in patients with hypertension (HTN), type 2 diabetes (T2D) and stable coronary artery disease (CAD).Material and methods. A total of 183 patients with CAD in combination with HTN and T2D took part in...
| الحاوية / القاعدة: | Рациональная фармакотерапия в кардиологии |
|---|---|
| المؤلفون الرئيسيون: | , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
Столичная издательская компания
2023-11-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://www.rpcardio.online/jour/article/view/2948 |